The global orally disintegrating tablet market size was valued at USD 14.76 billion in 2024 and is projected to grow from USD 16.33 billion in 2025 to USD 28.88 billion by 2033, exhibiting a CAGR of 7 ...
Zebra Technologies’ CEO Bill Burns discusses the company’s growth strategy and how it is enhancing frontline worker capabilities through machine vision, artificial intelligence and robotics ...
NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.
Many of today’s chips used in smartphones, tablets, and laptops are overseas. TSMC, the world’s largest semiconductor manufacturer, operates mainly in Taiwan and China. However, US President Donald ...